These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35201485)

  • 1. Focal adhesion kinase inhibitors, a heavy punch to cancer.
    Wu Y; Li N; Ye C; Jiang X; Luo H; Zhang B; Zhang Y; Zhang Q
    Discov Oncol; 2021 Nov; 12(1):52. PubMed ID: 35201485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting FAK in anticancer combination therapies.
    Dawson JC; Serrels A; Stupack DG; Schlaepfer DD; Frame MC
    Nat Rev Cancer; 2021 May; 21(5):313-324. PubMed ID: 33731845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting focal adhesion kinase in cancer cells and the tumor microenvironment.
    Murphy JM; Rodriguez YAR; Jeong K; Ahn EE; Lim SS
    Exp Mol Med; 2020 Jun; 52(6):877-886. PubMed ID: 32514188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study.
    Gao J; Cheng J; Xie W; Zhang P; Liu X; Wang Z; Zhang B
    Expert Opin Investig Drugs; 2024 Jun; 33(6):639-651. PubMed ID: 38676368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
    Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAK in Cancer: From Mechanisms to Therapeutic Strategies.
    Chuang HH; Zhen YY; Tsai YC; Chuang CH; Hsiao M; Huang MS; Yang CJ
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
    Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
    Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase: from biological functions to therapeutic strategies.
    Tan X; Yan Y; Song B; Zhu S; Mei Q; Wu K
    Exp Hematol Oncol; 2023 Sep; 12(1):83. PubMed ID: 37749625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors.
    Levy A; Alhazzani K; Dondapati P; Alaseem A; Cheema K; Thallapureddy K; Kaur P; Alobid S; Rathinavelu A
    Curr Cancer Drug Targets; 2019; 19(3):179-188. PubMed ID: 29984656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
    Lu Y; Sun H
    J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
    Chauhan A; Khan T
    Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and inhibitors of FAK in cancer: current advances and future directions.
    Hu HH; Wang SQ; Shang HL; Lv HF; Chen BB; Gao SG; Chen XB
    Front Pharmacol; 2024; 15():1274209. PubMed ID: 38410129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions.
    Mousson A; Sick E; Carl P; Dujardin D; De Mey J; Rondé P
    Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30134553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials.
    Mohanty A; Pharaon RR; Nam A; Salgia S; Kulkarni P; Massarelli E
    Expert Opin Investig Drugs; 2020 Apr; 29(4):399-409. PubMed ID: 32178538
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles of focal adhesion kinase in cancer.
    Tai YL; Chen LC; Shen TL
    Biomed Res Int; 2015; 2015():690690. PubMed ID: 25918719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an activated mutant of focal adhesion kinase: 'SuperFAK'.
    Gabarra-Niecko V; Keely PJ; Schaller MD
    Biochem J; 2002 Aug; 365(Pt 3):591-603. PubMed ID: 11988069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
    Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAK inhibitors in Cancer, a patent review.
    Lv PC; Jiang AQ; Zhang WM; Zhu HL
    Expert Opin Ther Pat; 2018 Feb; 28(2):139-145. PubMed ID: 29210300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway.
    Alfieri R; Giovannetti E; Bonelli M; Cavazzoni A
    Front Oncol; 2017; 7():170. PubMed ID: 28848709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.